#125193
Se está hablando de:
#125194
Re: Farmas USA
Difícil.que cuaje un mercado bajista, por Nico Garnier
https://inbestia.com/analisis/dificil-que-cuaje-un-mercado-bajista-con-macro-pmis-y-liquidez-rompiendo-maximos
https://inbestia.com/analisis/dificil-que-cuaje-un-mercado-bajista-con-macro-pmis-y-liquidez-rompiendo-maximos
«Después de nada, o después de todo/ supe que todo no era más que nada.»
#125195
Re: Farmas USA
¿Les has dicho algo? No sé pa qué tocan nada...
«Después de nada, o después de todo/ supe que todo no era más que nada.»
#125196
Re: Farmas USA
Si, le das a reportar a tu post y añades algo asi como "incidencia, error detectado'.
lo puede hacer todo el mundo
lo puede hacer todo el mundo
#125197
Re: Farmas USA
AMRN
https://newsfilter.io/a/67d287efd7cb35efed2d4bba1835abe2
Reported $156.5 million in net total revenue in the third quarter of 2020, an increase of 39% compared to the third quarter of 2019, resulting in net total revenue for the first nine months of $446.8 million, an increase of 56% compared to the same period in 2019.
Ahora se desplomara 😂😂😂. A ver si desmenuzo un poco mas.
Y al segundo Hikma
Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, has launched Icosapent Ethyl Capsules, 1gm, in the US through its US affiliate, Hikma Pharmaceuticals USA Inc.
Aqui no dan puntada sin hilo
https://newsfilter.io/a/67d287efd7cb35efed2d4bba1835abe2
Reported $156.5 million in net total revenue in the third quarter of 2020, an increase of 39% compared to the third quarter of 2019, resulting in net total revenue for the first nine months of $446.8 million, an increase of 56% compared to the same period in 2019.
Ahora se desplomara 😂😂😂. A ver si desmenuzo un poco mas.
Y al segundo Hikma
Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, has launched Icosapent Ethyl Capsules, 1gm, in the US through its US affiliate, Hikma Pharmaceuticals USA Inc.
Aqui no dan puntada sin hilo
Solo se que no se nada.
#125198
Re: Farmas USA
AMRN
Hikma se cubre las espaldas:
Hikma will be releasing limited quantities... The Company is working to scale up manufacturing and increase availability as soon as possible.
Hikma’s product is not approved for any other indication for the reference listed drug VASCEPA®
Hikma se cubre las espaldas:
Hikma will be releasing limited quantities... The Company is working to scale up manufacturing and increase availability as soon as possible.
Hikma’s product is not approved for any other indication for the reference listed drug VASCEPA®
Solo se que no se nada.
#125199
Re: Farmas USA
Reportado y arreglado.
«Después de nada, o después de todo/ supe que todo no era más que nada.»
#125200
Re: Farmas USA
GILD
Remdesivir shows superior to placebo in shortening time to recovery in adults hospitalized with COVID-19 - New England Journal of Medicine
https://www.nejm.org/doi/full/10.1056/NEJMoa2007764
Remdesivir shows superior to placebo in shortening time to recovery in adults hospitalized with COVID-19 - New England Journal of Medicine
https://www.nejm.org/doi/full/10.1056/NEJMoa2007764
«Después de nada, o después de todo/ supe que todo no era más que nada.»
